Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,065.00
+23.352.24%
Post-market: 1,064.59-0.4100-0.04%19:59 EDT
Volume:3.47M
Turnover:3.69B
Market Cap:1.01T
PE:37.83
High:1,070.34
Open:1,049.81
Low:1,047.07
Close:1,041.65
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:1.21
T/O Rate:0.37%
Dividend:6.23
Dividend Rate:0.58%
EPS(TTM):28.15
EPS(LYR):22.95
ROE:107.46%
ROA:20.74%
PB:32.27
PE(LYR):46.41

Loading ...

Eli Lilly (LLY) Is Up 6.0% After Bariatric‑Level Retatrutide Data – Has The Bull Case Changed?

Simply Wall St.
·
18 hours ago

Eli Lilly & Co Surges on Powerful Pipeline Hopes

TIPRANKS
·
Yesterday

Eli Lilly’s Engage Bio Acquisition Could Unlock A Genetic Medicine Goldmine!

Smartkarma
·
Yesterday

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
Yesterday

Centessa Pharmaceuticals Plc - Hsr Act Expiration Satisfies One Closing Condition for Lilly-Centessa Deal - SEC Filing

THOMSON REUTERS
·
Yesterday

Eli Lilly Expands Heart Failure Pipeline With New Phase 1 Trial of LY3971297

TIPRANKS
·
Yesterday

Eli Lilly’s Remternetug Study Reaches Completion, Setting the Stage in Alzheimer’s Drug Race

TIPRANKS
·
Yesterday

China's commerce ministry holds meeting with foreign pharmaceutical firms

Reuters
·
May 22

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS
·
May 22

Foundayo (Orforglipron), a Once-Daily Pill Taken Without Food or Water Restrictions, Was Associated With Reduced Body Weight by up to 13% in Adults 65 and Older With Obesity or Overweight, in New Analysis of Attain-1/2

THOMSON REUTERS
·
May 22

Eli Lilly: Starting July 1, 2026, Medicare Beneficiaries Can Access Foundayo Through Medicare Glp-1 Bridge at $50 Monthly Copay

THOMSON REUTERS
·
May 22

Is It Too Late To Consider Eli Lilly (LLY) After Its Recent Share Price Surge?

Simply Wall St.
·
May 22

Market Chatter: Novo Nordisk, Eli Lilly Weight-Loss Drugs Show Promise in Slowing, Preventing Cancer

MT Newswires Live
·
May 22

Studies suggest Ozempic, Mounjaro may slow tumor progression, WSJ reports

TIPRANKS
·
May 22

Eli Lilly's Next-Generation Anti-Obesity Drug Achieves Success in Pivotal Clinical Trial

Deep News
·
May 22

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Arvinas Holding Company (ARVN)

TIPRANKS
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Eli Lilly : Jefferies Raises Target Price to $1330 From $1300

THOMSON REUTERS
·
May 22

Eli Lilly's Next-Gen Obesity Drug Retatrutide Hits 28.3% Weight Loss in Phase 3 Trial, Rivaling Surgery

Deep News
·
May 22

Weight Loss Drugs Linked to Potential Cancer Risk Reduction, Boosting Prospects for Novo Nordisk and Eli Lilly

Deep News
·
May 22